Complementary Role of Hypothermia Identification to the Quick Sequential Organ Failure Assessment Score in Predicting Patients With Sepsis at High Risk of Mortality: A Retrospective Analysis From a Multicenter,Observational Study

Abstract

Background:

Although the quick Sequential Organ Failure Assessment (qSOFA) has been recommended for identifying patients at higher risk of hospital death, it has only a 60% sensitivity for in-hospital mortality. On the other hand, hypothermia associates with increased mortality and organ failure in patients with sepsis. This study aimed to assess the predictive validity of qSOFA for identifying patients with sepsis at higher risk of multiple organ dysfunction or death and the complementary effect of hypothermia.

Methods:

Patients with severe sepsis admitted to intensive care units (ICUs) were retrospectively analyzed. The predictive validities of qSOFA (≥2, positive) and the complementary effect of hypothermia (body temperature ≤36.5°C) for the identification of death or multiorgan dysfunction were evaluated.

Results:

Of the 624 patients, 230 (36.9%) developed multiorgan dysfunction and 144 (23.1%) died within 28 days; 527 (84.5%) had a positive qSOFA. The 28-day mortality rates of patients with positive and negative qSOFA were 25.4% and 10.3%, respectively (P = .001). The rate of positive qSOFA was higher in patients with multiorgan dysfunction (sensitivity, 0.896; specificity, 0.185) and among patients who died within 28 days (sensitivity, 0.931; specificity, 0.181); 10 (6.9%) of 144 deaths were not identified. In cases of positive qSOFA without hypothermia, positive qSOFA + hypothermia, or negative qSOFA with hypothermia, the predictive value for 28-day mortality improved (sensitivity, 0.979). Among the 144 patients who died, only 3 were not identified.

Conclusion:

A qSOFA score ≥2 may identify >90% of 28-day deaths among patients with severe sepsis; hypothermia may complement the predictive ability of qSOFA.

Keywords

critical care body temperature quick SOFA sepsis mortality

Get full access to this article

View all access options for this article.

References

Singer

Deutschman

Seymour

, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810.

Seymour

Liu

Iwashyna

, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762–774.

Le Gall

Klar

Lemeshow

, et al. The logistic organ dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA. 1996;276(10):802–810.

Surviving Sepsis Campaign Responds to Sepsis-3. In., vol. 2016. http://www.survivingsepsis.org/SiteCollectionDocuments/SSC-Statements-Sepsis-Definitions-3-2016.pdf: Antonelli

DeBacker

Dorman

Kleinpell

Levy

Rhodes

.; 2016. Accessed October 12, 2016.

Laupland

. Fever in the critically ill medical patient. Crit Care Med. 2009;37(suppl 7):S273–S278.

O’Grady

Barie

Bartlett

, et al. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med. 2008;36(4):1330–1349.

Kushimoto

Gando

Saitoh

, et al. The impact of body temperature abnormalities on the disease severity and outcome in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis. Crit Care. 2013;17(6):R271.

Fujishima

Gando

Saitoh

, et al. A multicenter, prospective evaluation of quality of care and mortality in Japan based on the Surviving Sepsis Campaign guidelines. J Infect Chemother. 2014;20(2):115–120.

Ogura

Gando

Saitoh

, et al. Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study. J Infect Chemother. 2014;20(3):157–162.

10.

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864–874.

11.

Levy

Fink

Marshall

, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250–1256.

12.

Knaus

Draper

Wagner

Zimmerman

. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829.

13.

Vincent

Moreno

Takala

, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med. 1996;22(7):707–710.

14.

Ferreira

Bota

Bross

Melot

Vincent

. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754–1758.

15.

Gando

Iba

Eguchi

, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006;34(3):625–631.

16.

Raith

Udy

Bailey

, et al. Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. 2016;317(3):290–300.

17.

Taylor

Jr Toh

Hoots

Wada

Levi

, Scientific subcommittee on disseminated intravascular coagulation of the international society on T, Haemostasis: towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5):1327–1330.

18.

Marik

Zaloga

. Hypothermia and cytokines in septic shock. Norasept II Study Investigators. North American study of the safety and efficacy of murine monoclonal antibody to tumor necrosis factor for the treatment of septic shock. Intensive Care Med. 2000;26(6):716–721.

19.

Clemmer

Fisher

Jr Bone

Slotman

Metz

Thomas

. Hypothermia in the sepsis syndrome and clinical outcome. the methylprednisolone severe sepsis study group. Crit Care Med. 1992;20(10):1395–1401.

20.

Veterans Administration Systemic Sepsis Cooperative Study G: Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med. 1987;317(11):659–665.

21.

Sprung

Peduzzi

Shatney

, et al. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med. 1990;18(8):801–806.

22.

Arons

Wheeler

Bernard

, et al. Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med. 1999;27(4):699–707.

23.

http://www.sccm.org/Research/Quality/Pages/Sepsis-Definitions.aspx:Sepsisdefinitions. Accessed October 12, 2016.

24.

http://www.sccm.org/SiteCollectionDocuments/Sepsis-Definitions-Infograf.png. Accessed October 12, 2016.

25.

Young

Saxena

Beasley

, et al. Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med. 2012;38(3):437–444.

26.

Laupland

Zahar

Adrie

, et al. Determinants of temperature abnormalities and influence on outcome of critical illness. Crit Care Med. 2012;40(1):145–151.

27.

Tiruvoipati

Ong

Gangopadhyay

Arora

Carney

Botha

. Hypothermia predicts mortality in critically ill elderly patients with sepsis. BMC Geriatr. 2010;10:70.

28.

Peres Bota

Lopes Ferreira

Melot

Vincent

. Body temperature alterations in the critically ill. Intensive Care Med. 2004;30(5):811–816.

29.

Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. The Veterans administration systemic sepsis cooperative study group. N Engl J Med. 1987;317(11):659–665.

30.

Lee

Inui

Suh

, et al. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Critical care. 2012;16(1):R33.